Live Breaking News & Updates on China National Drug Administration

Stay updated with breaking news from China national drug administration. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Innovent Announces the New Drug Application of IBI311 (IGF-1R antibody) has been Accepted by the NMPA of China for Thyroid Eye Disease

/PRNewswire/ Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes. ....

United States , Alia Teprotumumab , Eli Lilly , Innovent Biologics , Adimab Incyte , Group Of Oculoplastic , Group Of Thyroid Diseases , Md Anderson Cancer Center , Clinical Development Of Innovent , American Thyroid Society , Prnewswire Innovent Biologics Inc , Chinese Ophthalmology Branch , Chinese Academy Of Engineering , Chinese Medical Association , American Thyroid Association , Development Of Medicines , Chinese Endocrinology Branch , China National Drug Administration , Shanghai Jiaotong University School Of Medicine , European Group On Grave , European Group On Grave Orbitopathy , European Thyroid Society , European Thyroid Association , New Drug Application , Drug Evaluation , Thyroid Eye Disease ,

Biosyngen Announces FDA Fast Track Designation for BST02 in Treatment of Liver Cancer

Biosyngen is proud to announce that its latest groundbreaking product, BST02, has been granted Fast Track Designation (FTD) by the U.S. Food and Drug . ....

Michelle Chen , Drug Administration , Fast Track Designation , Drug Evaluation , China National Drug Administration ,

Biosyngen Announces FDA Fast Track Designation for BST02 in Treatment of Liver Cancer

/PRNewswire/ Biosyngen is proud to announce that its latest groundbreaking product, BST02, has been granted Fast Track Designation (FTD) by the U.S. Food. ....

Michelle Chen , Prnewswire Biosyngen , Drug Administration , Fast Track Designation , Drug Evaluation , China National Drug Administration ,

FDA Grants Fast Track Designation to BST02 for Liver Cancer

The FDA has granted a fast track designation to the T-cell therapy BST02 for the treatment of patients with all forms of liver cancer. ....

China National Drug Administration , Common Adverse Event Evaluation , Fast Track Designation , Liver Cancer , Hepatocellular Carcinoma ,

Pulnovo Medical Announces PADN Receives FDA HUD Designation and US CMS Medicare Coverage Code and NMPA Approval

Pulnovo Medical Announces PADN Receives FDA HUD Designation and US CMS Medicare Coverage Code and NMPA Approval
sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

United States , Us Medicare Medicaid Services , China National Drug Administration , American Medical Association , Pulnovo Medical , Pulnovo Medical Limited , Pulmonary Hypertension , Heart Failure , Humanitarian Use Device , National Drug Administration , Medicaid Services , Arterial Hypertension , Multi Pole Pulmonary Artery , Breakthrough Device Designation , Medical Limited ,